Nicole McNeer

1.1k total citations
15 papers, 526 citations indexed

About

Nicole McNeer is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Nicole McNeer has authored 15 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Genetics. Recurrent topics in Nicole McNeer's work include RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (8 papers) and CRISPR and Genetic Engineering (4 papers). Nicole McNeer is often cited by papers focused on RNA Interference and Gene Delivery (11 papers), Advanced biosensing and bioanalysis techniques (8 papers) and CRISPR and Genetic Engineering (4 papers). Nicole McNeer collaborates with scholars based in United States, Japan and South Africa. Nicole McNeer's co-authors include Peter M. Glazer, W. Mark Saltzman, Rachel J. Fields, Erica Schleifman, Raman Bahal, Elias Quijano, Joanna Chin, Christina Caputo, Marie E. Egan and Danith H. Ly and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Nicole McNeer

13 papers receiving 521 citations

Peers

Countries citing papers authored by Nicole McNeer

Since Specialization

Citations

This map shows the geographic impact of Nicole McNeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole McNeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole McNeer more than expected).

Fields of papers citing papers by Nicole McNeer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole McNeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole McNeer. The network helps show where Nicole McNeer may publish in the future.

Co-authorship network of co-authors of Nicole McNeer

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole McNeer. A scholar is included among the top collaborators of Nicole McNeer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole McNeer. Nicole McNeer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A phase 1b/2, safety lead-in and dose-expansion trial of ivosidenib plus durvalumab and gemcitabine/cisplatin as first-line therapy in patients with locally advanced, unresectable or metastatic cholangiocarcinoma with an IDH1 mutation. 2025 ·Journal of Clinical Oncology ·James J. Harding, Anthony B. El-Khoueiry, (unknown), Hong Jae Chon, Jin Won Kim, Hye Jin Choi, (unknown), (unknown), Camelia Gliser, Nicole McNeer, (unknown)	0
2	Proteomic Barcoding Platform for Macromolecular Screening and Delivery 2024 ·Journal of Proteome Research ·Ning Wang, Nicole McNeer, Elliot O. Eton, Josh Fass, Alex Kentsis	0
3	Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience 2022 ·Blood ·Ghayas C. Issa, Branko Cuglievan, Eytan M. Stein, Martha Arellano, (unknown), Nandita Khera, Richard M. Stone, Michael J. Thirman, John F. DiPersio, Nicole Karras, (unknown), Rebecca G. Bagley, (unknown), David Tamang, (unknown), (unknown), Michael L. Meyers, (unknown), Nicole McNeer, Ibrahim Aldoss	3
4	NIMBLE: A Phase I/II Study of AZD0466 Monotherapy or in Combination in Patients with Advanced Hematological Malignancies 2021 ·Blood ·Marina Konopleva, Nitin Jain, Courtney L. Andersen, (unknown), Nairouz Elgeioushi, (unknown), Martin Scott, John Stone, Shringi Sharma, Pablo Morentin Gutierrez, Raoul Tibes, Barry R. Davies, Thomas Winkler, Giulia Fabbri, Fathima Zumla Cader, Nicole McNeer	5
5	Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia 2019 ·Leukemia ·Nicole McNeer, John Philip, Heather Geiger, Rhonda E. Ries, Vincent‐Philippe Lavallée, Michael F. Walsh, Minita Shah, Kanika Arora, Anne‐Katrin Emde, Nicolas Robine, Todd A. Alonzo, E. Anders Kolb, Alan S. Gamis, Malcolm A. Smith, Daniela S. Gerhard, (unknown), Soheil Meshinchi, Alex Kentsis	77
6	Abstract 2870: Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia 2019 ·Tumor Biology ·Nicole McNeer, John Philip, Heather Geiger, Rhonda E. Ries, Vincent‐Philippe Lavallée, Michael F. Walsh, Minita Shah, Kanika Arora, Anne‐Katrin Emde, Nicolas Robine, Todd A. Alonzo, E. Anders Kolb, Alan S. Gamis, Malcolm A. Smith, Daniela S. Gerhard, (unknown), Soheil Meshinchi, Alex Kentsis	1
7	Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium 2015 ·Nature Communications ·Nicole McNeer, (unknown), Rachel J. Fields, Christina Caputo, Sascha Kopic, Anisha Gupta, Elias Quijano, Lee Polikoff, Yong Kong, Raman Bahal, John P. Geibel, Peter M. Glazer, W. Mark Saltzman, Marie E. Egan	113
8	Single-Stranded γPNAs for In Vivo Site-Specific Genome Editing via Watson-Crick Recognition 2014 ·Current Gene Therapy ·Raman Bahal, Elias Quijano, Nicole McNeer, Yanfeng Liu, Dinesh C. Bhunia, (unknown), Rachel J. Fields, W. Mark Saltzman, Danith H. Ly, Peter M. Glazer	39
9	Targeted Genome Modification via Triple Helix Formation 2014 ·Methods in molecular biology ·Adele S. Ricciardi, Nicole McNeer, (unknown), W. Mark Saltzman, Peter M. Glazer	20
10	Modified Poly(lactic‐co‐glycolic Acid) Nanoparticles for Enhanced Cellular Uptake and Gene Editing in the Lung 2014 ·Advanced Healthcare Materials ·Rachel J. Fields, Elias Quijano, Nicole McNeer, Christina Caputo, Raman Bahal, (unknown), Marie E. Egan, Peter M. Glazer, W. Mark Saltzman	35
11	Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice 2013 ·Molecular Therapy — Nucleic Acids ·Erica Schleifman, Nicole McNeer, Andrew Jackson, (unknown), Michael A. Brehm, Leonard D. Shultz, Dale L. Greiner, Priti Kumar, W. Mark Saltzman, Peter M. Glazer	35
12	Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5 2013 ·PubMed ·Raman Bahal, Nicole McNeer, Danith H. Ly, W. Mark Saltzman, Peter M. Glazer	36
13	Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo 2012 ·Gene Therapy ·Nicole McNeer, Erica Schleifman, Amy Cuthbert, Michael A. Brehm, Andrew Jackson, Christopher H.K. Cheng, (unknown), Priti Kumar, Leonard D. Shultz, Dale L. Greiner, W. Mark Saltzman, Peter M. Glazer	68
14	Polymer delivery systems for site-specific genome editing 2011 ·Journal of Controlled Release ·Nicole McNeer, Erica Schleifman, Peter M. Glazer, W. Mark Saltzman	13
15	Nanoparticles Deliver Triplex-forming PNAs for Site-specific Genomic Recombination in CD34+ Human Hematopoietic Progenitors 2010 ·Molecular Therapy ·Nicole McNeer, Joanna Chin, Erica Schleifman, Rachel J. Fields, Peter M. Glazer, W. Mark Saltzman	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact